Baker McKenzie: KD Pharma Group acquires dsm-firmenich’s marine lipids business
Baker McKenzie advised KD Pharma Group, a global producer of pharmaceutical and nutritional lipids, on the acquisition of dsm-firmenich’s marine lipids business in exchange for a minority stake in KD Pharma Group. The transaction is expected to close towards the end of 2024 and is subject to customary regulatory approvals.
The transaction includes dsm-firmenich’s Marine Lipids fish oil omega-3 business for the food and beverage, dietary supplements and pharmaceutical markets, together with the MEG-3 brand and the production facilities in Piura/Peru and Mulgrave/Canada.
Baker McKenzie’s team
Corporate/M&A partner Dr Tino Marz, based in Munich, led Baker McKenzie’s team, which further comprised Liliana Espinosa (partner, Lima), Eva Kriechbaumer (senior associate, Munich), Erik Kuhn (associate, Munich), Jan Neumann (associate, Munich), Katherine Zapata (associate, Lima), Cosima König-Mancini (senior associate, Milan) – all corporate/M&A – ; tax partner Thomas Gierath (based in Munich);
Jan Kresken (partner, Düsseldorf), Roger Thomi (partner, Zurich), Markus Mossmann (associate, Düsseldorf) – all antitrust & competition -; Patrick Wilkening (partner, Düsseldorf), Dr Moritz Sutterer (associate, Munich), Nadine Charrière (associate, Zurich) – all IP – ; dispute resolution associate Cédric Pittet (Zurich); partner Katharina Spenner (Munich), Joachim Fröhlich (counsel, Munich) – both commercial & trade -; real estate senior associate Ricardo Canepa (Lima), employment partner Christian Koops (Munich) and natural resources & environmental law senior associate Nicole Freire (Lima).
KD Pharma Group
The KD Pharma Group is a manufacturer of active ingredients for omega-3 pharmaceuticals and omega-3 dietary supplements as well as formulation and encapsulation services. With more than 500 employees, the group is represented in the UK, Norway, Germany, Switzerland and the USA.
dsm-firmenich
dsm-firmenich is a Swiss-Dutch company, listed on Euronext Amsterdam, that operates in almost 60 countries with around 30,000 employees and generates sales of more than 12 billion euros.
